2024 Q3 Form 10-Q Financial Statement

#000076889924000102 Filed on August 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $382.4M $396.2M
YoY Change -19.2% -16.69%
Cost Of Revenue $282.3M $291.8M
YoY Change -19.11% -15.44%
Gross Profit $100.0M $104.4M
YoY Change -19.44% -19.98%
Gross Profit Margin 26.16% 26.35%
Selling, General & Admin $99.97M $97.02M
YoY Change -17.18% -18.97%
% of Gross Profit 99.94% 92.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.967M $7.691M
YoY Change 12.66% 22.47%
% of Gross Profit 6.96% 7.37%
Operating Expenses $99.97M $97.02M
YoY Change -17.18% -23.0%
Operating Profit -$6.903M -$59.96M
YoY Change 153.23% -1436.3%
Interest Expense $2.620M $1.438M
YoY Change -2643.69% -246.73%
% of Operating Profit
Other Income/Expense, Net $521.0K $1.741M
YoY Change 33.59% 201.21%
Pretax Income -$6.382M -$58.22M
YoY Change 173.2% 873.89%
Income Tax $1.253M $46.49M
% Of Pretax Income
Net Earnings -$7.635M -$104.7M
YoY Change 76250.0% 1329.88%
Net Earnings / Revenue -2.0% -26.43%
Basic Earnings Per Share -$0.26 -$3.45
Diluted Earnings Per Share -$0.26 -$3.45
COMMON SHARES
Basic Shares Outstanding 29.83M shares 30.57M shares
Diluted Shares Outstanding 29.70M shares 30.35M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.51M $26.40M
YoY Change -69.21% -46.83%
Cash & Equivalents $14.51M $26.40M
Short-Term Investments
Other Short-Term Assets $5.109M $5.093M
YoY Change -11.23% -77.69%
Inventory
Prepaid Expenses
Receivables $225.4M $231.1M
Other Receivables $10.89M $10.61M
Total Short-Term Assets $285.3M $300.6M
YoY Change -20.66% -15.03%
LONG-TERM ASSETS
Property, Plant & Equipment $91.08M $92.10M
YoY Change -11.41% -39.9%
Goodwill $25.29M $24.91M
YoY Change -70.17% -70.71%
Intangibles $6.428M $7.027M
YoY Change -45.63% -46.61%
Long-Term Investments
YoY Change
Other Assets $13.01M $13.67M
YoY Change -6.03% -94.51%
Total Long-Term Assets $417.1M $423.0M
YoY Change -24.91% -25.91%
TOTAL ASSETS
Total Short-Term Assets $285.3M $300.6M
Total Long-Term Assets $417.1M $423.0M
Total Assets $702.4M $723.7M
YoY Change -23.24% -21.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $35.77M $36.11M
YoY Change -26.82% -25.64%
Accrued Expenses $113.7M $116.5M
YoY Change -20.82% -16.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $154.6M $158.0M
YoY Change -22.93% -20.69%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.449M $1.339M
YoY Change -3.14% -99.51%
Total Long-Term Liabilities $1.449M $1.339M
YoY Change -3.14% -99.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $154.6M $158.0M
Total Long-Term Liabilities $1.449M $1.339M
Total Liabilities $375.2M $385.9M
YoY Change -18.15% -18.03%
SHAREHOLDERS EQUITY
Retained Earnings $347.3M $358.3M
YoY Change -27.3% -24.38%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $327.2M $337.8M
YoY Change
Total Liabilities & Shareholders Equity $702.4M $723.7M
YoY Change -23.24% -21.75%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$7.635M -$104.7M
YoY Change 76250.0% 1329.88%
Depreciation, Depletion And Amortization $6.967M $7.691M
YoY Change 12.66% 22.47%
Cash From Operating Activities -$7.127M -$1.823M
YoY Change 450.35% -115.56%
INVESTING ACTIVITIES
Capital Expenditures $5.595M $5.904M
YoY Change -23.95% -22.89%
Acquisitions
YoY Change
Other Investing Activities $9.468M -$326.0K
YoY Change -239.81% -109.04%
Cash From Investing Activities $3.873M -$6.230M
YoY Change -127.41% 53.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.246M -6.857M
YoY Change 311.04% -27.6%
NET CHANGE
Cash From Operating Activities -7.127M -1.823M
Cash From Investing Activities 3.873M -6.230M
Cash From Financing Activities -4.246M -6.857M
Net Change In Cash -7.500M -14.91M
YoY Change -54.43% 724.21%
FREE CASH FLOW
Cash From Operating Activities -$7.127M -$1.823M
Capital Expenditures $5.595M $5.904M
Free Cash Flow -$12.72M -$7.727M
YoY Change 47.04% -290.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99306000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
135631000 usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
tbi Payments To Acquire Restricted Investments Held To Maturity
PaymentsToAcquireRestrictedInvestmentsHeldToMaturity
10180000 usd
tbi Payments To Acquire Restricted Investments Held To Maturity
PaymentsToAcquireRestrictedInvestmentsHeldToMaturity
9955000 usd
tbi Proceeds From Maturity Of Restricted Investments Heldtomaturity
ProceedsFromMaturityOfRestrictedInvestmentsHeldtomaturity
19220000 usd
tbi Proceeds From Maturity Of Restricted Investments Heldtomaturity
ProceedsFromMaturityOfRestrictedInvestmentsHeldtomaturity
15613000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5311000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12427000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
16986000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
34200000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
417000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
509000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2143000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2514000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-91000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20519000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-36296000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-557000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-20000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-42449000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27879000 usd
us-gaap Interest Paid Net
InterestPaidNet
498000 usd
us-gaap Interest Paid Net
InterestPaidNet
453000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-199000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3760000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
7635000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
7793000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1864000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3345000 usd
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
244453000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
84114000 usd
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1807000 usd
us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
600000 usd
us-gaap Noncash Or Part Noncash Divestiture Amount Of Consideration Received1
NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6654000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8124000 usd
CY2024Q2 us-gaap Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount
ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
0.20
CY2024Q2 us-gaap Government Assistance Amount Cumulative
GovernmentAssistanceAmountCumulative
15100000 usd
CY2024Q2 us-gaap Assets Held By Insurance Regulators
AssetsHeldByInsuranceRegulators
23896000 usd
CY2023Q4 us-gaap Assets Held By Insurance Regulators
AssetsHeldByInsuranceRegulators
23598000 usd
CY2024Q2 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
5816000 usd
CY2023Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
12703000 usd
CY2024Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
113268000 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
122659000 usd
CY2024Q2 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
39627000 usd
CY2023Q4 us-gaap Life Insurance Corporate Or Bank Owned Amount
LifeInsuranceCorporateOrBankOwnedAmount
32905000 usd
CY2024Q2 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
745000 usd
CY2023Q4 us-gaap Other Restricted Assets Noncurrent
OtherRestrictedAssetsNoncurrent
1120000 usd
CY2024Q2 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
183352000 usd
CY2023Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
192985000 usd
CY2024Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
113268000 usd
CY2024Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
124000 usd
CY2024Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
2221000 usd
CY2024Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
111171000 usd
CY2023Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
122659000 usd
CY2023Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
533000 usd
CY2023Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
2279000 usd
CY2023Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
120913000 usd
CY2024Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
303000 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1558000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2005000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3212000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
630000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2408000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1785000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2130000 usd
us-gaap Financing Receivable Allowance For Credit Loss Foreign Currency Translation
FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
1000 usd
us-gaap Financing Receivable Allowance For Credit Loss Foreign Currency Translation
FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation
-3000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
849000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3493000 usd
CY2024Q2 tbi Prepaid Software Agreements Current
PrepaidSoftwareAgreementsCurrent
9666000 usd
CY2023Q4 tbi Prepaid Software Agreements Current
PrepaidSoftwareAgreementsCurrent
8435000 usd
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
6023000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
9355000 usd
CY2024Q2 us-gaap Assets Held For Sale Not Part Of Disposal Group Current Other
AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther
11785000 usd
CY2023Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current Other
AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther
4845000 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
5093000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
6259000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32567000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
28894000 usd
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
328567000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
59074000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-126000 usd
CY2024Q2 us-gaap Goodwill Gross
GoodwillGross
328441000 usd
CY2024Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
303527000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
24914000 usd
CY2024Q2 us-gaap Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount
ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
0.20
tbi Weighted Average Period Claim Payments Below Deductible Limit
WeightedAveragePeriodClaimPaymentsBelowDeductibleLimit
P5Y6M
CY2024Q2 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
195364000 usd
CY2023Q4 us-gaap Workers Compensation Liability Current And Noncurrent
WorkersCompensationLiabilityCurrentAndNoncurrent
214611000 usd
CY2024Q2 tbi Workers Compensation Discount Reserve Amount
WorkersCompensationDiscountReserveAmount
17385000 usd
CY2023Q4 tbi Workers Compensation Discount Reserve Amount
WorkersCompensationDiscountReserveAmount
18096000 usd
CY2024Q2 tbi Workers Compensation Liability Netof Discount
WorkersCompensationLiabilityNetofDiscount
177979000 usd
CY2023Q4 tbi Workers Compensation Liability Netof Discount
WorkersCompensationLiabilityNetofDiscount
196515000 usd
CY2024Q2 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
38728000 usd
CY2023Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
44866000 usd
CY2024Q2 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
139251000 usd
CY2023Q4 us-gaap Workers Compensation Liability Noncurrent
WorkersCompensationLiabilityNoncurrent
151649000 usd
us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
21600000 usd
us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
22400000 usd
tbi Weighted Average Period Claim Payments And Receivables Above Deductible Limit
WeightedAveragePeriodClaimPaymentsAndReceivablesAboveDeductibleLimit
P18Y
CY2024Q2 tbi Discountedworkerscompensationreserveforexcessclaims
Discountedworkerscompensationreserveforexcessclaims
51200000 usd
CY2023Q4 tbi Discountedworkerscompensationreserveforexcessclaims
Discountedworkerscompensationreserveforexcessclaims
54900000 usd
CY2024Q2 tbi Workers Compensation Claim Receivables
WorkersCompensationClaimReceivables
50400000 usd
CY2023Q4 tbi Workers Compensation Claim Receivables
WorkersCompensationClaimReceivables
53800000 usd
CY2024Q2 tbi Workers Compensation Expense
WorkersCompensationExpense
4800000 usd
CY2023Q2 tbi Workers Compensation Expense
WorkersCompensationExpense
5900000 usd
CY2024Q2 tbi Debt Instrument Fixed Charge Coverage Ratio
DebtInstrumentFixedChargeCoverageRatio
8.72
CY2024Q2 tbi Debt Instrument Covenant Accounts Receivable Threshold Percentage
DebtInstrumentCovenantAccountsReceivableThresholdPercentage
0.60
CY2024Q2 tbi Debt Instrument Covenant Restricted Cash Threshold
DebtInstrumentCovenantRestrictedCashThreshold
50000000 usd
CY2024Q2 tbi Debt Instrument Covenant Aggregate Share Repurchase Limit
DebtInstrumentCovenantAggregateShareRepurchaseLimit
25000000 usd
CY2024Q2 tbi Debt Instrument Asset Coverage Ratio Threshold
DebtInstrumentAssetCoverageRatioThreshold
22.43
CY2024Q2 tbi Debt Instrument Consolidated Leverage Ratio Threshold
DebtInstrumentConsolidatedLeverageRatioThreshold
3.00
CY2024Q2 tbi Collateral Commitments Cash Collateral Held By Insurance Carriers
CollateralCommitmentsCashCollateralHeldByInsuranceCarriers
18030000 usd
CY2023Q4 tbi Collateral Commitments Cash Collateral Held By Insurance Carriers
CollateralCommitmentsCashCollateralHeldByInsuranceCarriers
17737000 usd
CY2024Q2 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
5816000 usd
CY2023Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
12703000 usd
CY2024Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
113268000 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
122659000 usd
CY2024Q2 tbi Collateral Commitments Lettersof Credit
CollateralCommitmentsLettersofCredit
6077000 usd
CY2023Q4 tbi Collateral Commitments Lettersof Credit
CollateralCommitmentsLettersofCredit
6077000 usd
CY2024Q2 tbi Collateral Commitments Surety Bonds
CollateralCommitmentsSuretyBonds
20725000 usd
CY2023Q4 tbi Collateral Commitments Surety Bonds
CollateralCommitmentsSuretyBonds
20725000 usd
CY2024Q2 tbi Collateral Commitments Total Collateral Commitments
CollateralCommitmentsTotalCollateralCommitments
163916000 usd
CY2023Q4 tbi Collateral Commitments Total Collateral Commitments
CollateralCommitmentsTotalCollateralCommitments
179901000 usd
tbi Collateral Commitments Surety Bond Annual Fee Limit Percentage Of Bond Amount
CollateralCommitmentsSuretyBondAnnualFeeLimitPercentageOfBondAmount
0.020
tbi Collateral Commitments Surety Bonds Required Cancellation Notice
CollateralCommitmentsSuretyBondsRequiredCancellationNotice
P60D
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
221000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
506000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
221000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
506000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
337764000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
454045000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.475
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-104710000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-7323000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30349000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30966000 shares
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30349000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30966000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.45
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.45
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1530000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
967000 shares
tbi Number Of Reportable Segments Aggregated From Operating Segments
NumberOfReportableSegmentsAggregatedFromOperatingSegments
1 segment
tbi Number Of Reportable Segments Aggregated From Operating Segments
NumberOfReportableSegmentsAggregatedFromOperatingSegments
1 segment
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
396230000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
475588000 usd
CY2024Q2 tbi Operating Profit Loss From Segments
OperatingProfitLossFromSegments
7219000 usd
CY2023Q2 tbi Operating Profit Loss From Segments
OperatingProfitLossFromSegments
19225000 usd
CY2024Q2 tbi Work Opportunity Tax Credit Processing Fees
WorkOpportunityTaxCreditProcessingFees
90000 usd
CY2023Q2 tbi Work Opportunity Tax Credit Processing Fees
WorkOpportunityTaxCreditProcessingFees
110000 usd
CY2024Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1452000 usd
CY2023Q2 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
952000 usd
CY2024Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
59674000 usd
CY2023Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
9485000 usd
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
39000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
174000 usd
CY2024Q2 tbi Covid19 Government Subsidies Net
COVID19GovernmentSubsidiesNet
9696000 usd
CY2023Q2 tbi Covid19 Government Subsidies Net
COVID19GovernmentSubsidiesNet
0 usd
CY2024Q2 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
1779000 usd
CY2023Q2 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
565000 usd
us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
3988000 usd
us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
1962000 usd
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7691000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6280000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
15649000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
12691000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-59960000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6556000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-75469000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-12499000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1741000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
578000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3340000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1592000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58219000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5978000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-72129000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10907000 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
tbi-20240630_cal.xml Edgar Link unprocessable
0000768899-24-000102-index-headers.html Edgar Link pending
0000768899-24-000102-index.html Edgar Link pending
0000768899-24-000102.txt Edgar Link pending
0000768899-24-000102-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbi-20240630.htm Edgar Link pending
tbi-20240630.xsd Edgar Link pending
tbi-20240630_g1.jpg Edgar Link pending
tbi10q063024ex101.htm Edgar Link pending
tbi10q063024ex311.htm Edgar Link pending
tbi10q063024ex312.htm Edgar Link pending
tbi10q063024ex321.htm Edgar Link pending
tbi-20240630_def.xml Edgar Link unprocessable
tbi-20240630_lab.xml Edgar Link unprocessable
tbi-20240630_pre.xml Edgar Link unprocessable
tbi-20240630_htm.xml Edgar Link completed